The global clinical trial report- “2019 Rosacea Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Rosacea. It presents in-depth analysis of Rosacea clinical trials across markets and companies. The research work is for providing complete understanding into trends in Rosacea.
The report covers a key snapshot of trial trends, enrollment trends, success trends, locations and other trends.
It also segments the Rosacea clinical trials by- • Current Trial Status • Type of the trial • Sponsor Type • Enrollment Trends • Region • Countries • Trial Phase
The report also identifies the potential drug candidates under development for treatment of Rosacea
The research work is prepared through extensive and continuous research on Rosacea trials from over 1500 sources including company websites, conferences and presentations, scientific journals, country wise and global clinical trial registries, news, health and science departments among others.
Report Scope and Coverage: • All major trials from 2010 to 2019 and planned trials are included in the report scope. • Drug candidates currently being researched for administering Rosacea patients are identified • The report includes panorama of Rosacea clinical trials across the globe • Trial Phase, Current Status, Sponsor Type, Location, trial type and Enrollment details are provided • Companies and universities focusing on Rosacea clinical trials are analyzed along with their trial participation (trial title, trial phase and current status) • Average Enrollment number, insights into enrollment trends, company wise enrollment are included • Both interventional and observational studies are analyzed • News and latest developments for the past one year are presented in the report
Our reports have been used by over 10K customers, including:
Biopreservation refers to the process of preserving cells, tissues or organs outside of their native environment for extended period of time. It has emerged as an effective preservation technique for long-term storage. Owing to this, biopreservation has become vital for the success of various clinical and commercial...
Healthcare Contract Research Organization Market Size, Share & Trends Analysis Report By Type (Drug Discovery, Pre-clinical, Clinical), By Service (Clinical Monitoring, Regulatory/Medical Affairs), And Segment Forecasts, 2021 - 2028 Healthcare CRO Market Growth & Trends The global healthcare...
The comprehensive 2,400 page research study on COVID-19 therapeutic and vaccine pipeline candidates, completed, ongoing and planned clinical trials across phases, countries, companies and institutes/hospitals. The global COVID-19 market size outlook remains robust driven by huge potential for administration to 2 billion populations,...
Report Scope:
This report analyzes the regulatory framework for the clinical trials of orphan drugs in rare and orphan diseases.The report also analyzes the trends and characteristics of clinical trials conducted on rare diseases from 1999-2018, using information from various sources.
This report covers an overview...
Pharmacovigilance Market Size, Share & Trends Analysis Report By Service Provider (In-house, Contract Outsourcing), By Product Life Cycle, By Type, By Process Flow, By Therapeutic Area, By End Use, And Segment Forecasts, 2021 - 2028
Pharmacovigilance Market Growth & Trends
The global pharmacovigilance...
Certain factors that are driving the market growth include rising healthcare expenditure, growing burden of chronic diseases and advances in drug discovery and development. The burden of chronic diseases is increasing worldwide. According to WHO, chronic diseases have always been a massive global challenge, and they account for approximately...
Summary Cochlear Ltd (Cochlear) is a medical device company that offers implantable hearing solutions.It develops, manufactures and markets electronic implantable hearing devices. The company’s products are suited for people with hearing loss caused by ear nerve damage.Its major products include cochlear implant...
The microplate reader market was valued at US$ 534.5 million in 2019 and is projected to reach US$ 704.4 million by 2027; it is expected to grow at a CAGR of 3.6% during 2020–2027. The market is attributed to increasing research and development in the pharmaceuticals industry, and escalating incidence of infectious diseases. However, high...
Impetigo Pipeline Overview
The Q4 Impetigo pipeline report is part of the VPA 110 Infectious Disease pipeline service. This quarterly review describes the pipeline of drugs under development for Impetigo, provides an update on the mechanism of action and targets, licensing and collaboration opportunities, company...
Dermatological Condition
Drug Development
Therapy
World
By continuing to use this site you consent to the use of cookies on your device as described in our Cookie Policy unless you have disabled them.
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.